Drug Profile
Research programme: G protein-coupled receptor modulators - Brigitte Kieffer Laboratory/Domain Therapeutics/Prestwick Chemicals
Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Domain Therapeutics; Institute of Genetics and Molecular and Cellular Biology; Prestwick Chemical
- Developer Domain Therapeutics
- Class Small molecules
- Mechanism of Action G protein-coupled receptor modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Schizophrenia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for research development in Schizophrenia in France